Inside Aesthetics Ep 169 The Tox Talks (Chapter 2): Alluzience/Liquid Abobotulinum | Dr Christoph Martschin
Episode 169 hosts Dr Christoph Martschin (Dermatologist based in Lisbon, Portugal)
Christophe has been a Galderma KOL since 2011. As a global speaker and trainer, he has a wealth of knowledge when it comes to Galderma's portfolio and research projects.
In this mini series 'The Tox Talks', we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.
In chapter 2 we focus on a newly launched brand called 'Alluzience', (Abobotulinum toxin A), a novel toxin developed by Galderma that is the world's first liquid toxin.
00:00 Introduction 01:03 Dr Christoph Martschin 04:55 Why Liquid Toxin Was Developed 10:59 How Alluzience Differs From Traditional Toxins 18:27 Faster Onset and Longer Duration Explained 26:25 Patient Demand for Convenience and Flexibility 33:29 Practical Benefits of Pre Diluted Toxin 41:37 Reducing Human Error and Improving Consistency 48:53 Sustainability and Reduced Clinical Waste 52:09 Managing Patient Expectations With Longer Duration 61:45 Pricing, Profitability and Clinic Workflow 68:49 Comfort During Injection and Treatment Experience 76:38 When to Use Different Toxin Options 80:09 Consultation Approach and Treatment Planning 86:34 Safety Profile and Real World Performance 90:43 Future of Neuromodulators and New Product Innovation